Literatur
- 1
Messing E M. et al .
Eastern Cooperative Oncology Group/Intergroup trial: Phase III study of interferon
alfa-NL as adjuvant treatment for respectable renal cell carcinoma: an Eastern Cooperative
Oncology Group/Intergroup trial.
J Clin Oncol.
2003;
21
1214-1222
- 2
Clark J I. et al .
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma:
a cytokine working group randomized trial.
J Clin Oncol.
2003;
21
3133-3140
- 3
Jocham D. et al .
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients
with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled
trial.
Lancet.
2004;
363
594-599
Priv.-Doz. Dr. med. Stefan Corvin
Prof. Dr. med. Arnulf Stenzl
Klinik für Urologie, Eberhard-Karls-Universität
Hoppe-Seyler-Straße 3
72076 Tübingen
